P.MillerN
Janumet is designed for adults diagnosed with type 2 diabetes
*Correspondence: Lukasz Dzialach, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
The additional activation of glucagon helps accelerate fat loss, reduce fat storage, and further suppress appetite
6.6 Effects on renal functions The result of clinical trials of tirzepatide on kidney function indicates potential renal advantages, especially in individuals with type-2 diabetes (T2D) and a heightened cardiovascular risk.In the SURPASS-4 (NCT03730662) trial, tirzepatide was observed to reduce occurrence of the composite kidney endpoint (like eGFR decline of at least 40% from baseline, end-stage kidney disease, death due to kidney failure, or new-onset macro albuminuria) in comparison to those receiving insulin glargine
And more serious, but rare, side effects will also be the same that includes pancreatitis, bowel obstruction or gallstone attacks